Medication info
Losarca Tablet 5/50 mg

Losarca Tablet 5/50 mg

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Hanmi United Pharm, Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
For domestic use - 30 tablets/bottle, for export - 30 tablets/box [(10 tablets/PTPX3)]
Approval status
Active

MFDS item code 201504051 · Approved 2015.06.19 · Insurance code 644308940

Summary

Main use
Initial treatment of essential hypertension inadequately controlled with monotherapy and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual ingredients (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual ingredients as follows, switching directly to this medicine may be considered. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination product compared with monotherapy. Usually, this medicine is administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients undergoing dialysis. ○ Patients with reduced effective circulating blood volume: Administration of this medicine is not recommended for a small number of patients with reduced intravascular volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or above, an initial dose of losartan of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, administration is not recommended.

Ingredients

Manufacturer
Hanmi United Pharm, Co., Ltd.

Efficacy & effects

Initial treatment of essential hypertension inadequately controlled with monotherapy and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or losartan. It is also used as a first-line treatment for patients with stage 2 hypertension who require multiple medications to achieve target blood pressure. It helps effectively lower and manage blood pressure.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual ingredients (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual ingredients as follows, switching directly to this medicine may be considered. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination product compared with monotherapy. Usually, this medicine is administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients undergoing dialysis. ○ Patients with reduced effective circulating blood volume: Administration of this medicine is not recommended for a small number of patients with reduced intravascular volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or above, an initial dose of losartan of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, administration is not recommended.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Care should be taken as hypotension may occur upon initial administration in patients with reduced blood volume. It should not be used in patients with hypersensitivity to any of its components, pregnant or potentially pregnant women, nursing mothers, patients with severe liver impairment, severe aortic stenosis, and those in shock. It should be administered cautiously in patients with decreased blood volume, rigorous sodium restriction, moderate to severe renal impairment, and hyperkalemia. Various side effects like dizziness, headache, drowsiness, edema, blood pressure reduction, dyspepsia, skin rash, etc., may occur; if symptoms are severe, consult a physician. Especially, dizziness may occur due to the blood pressure-lowering effect, thus avoiding dangerous activities like working at heights or operating vehicles is advisable. It is safer to avoid this drug during lactation as it may be excreted in breast milk. This drug is not recommended for children under 18 years, as the safety and efficacy have not been established. Caution is needed for elderly patients over 75 years as appropriate dosage adjustment may be difficult. When taken with other antihypertensives, caution must be exercised according to a physician's instructions, as the effects may be enhanced. Overdosing may result in severe hypotension or cardiac issues, so adherence to prescribed doses is crucial, and medical attention should be sought immediately if adverse symptoms occur. Store out of reach of children and do not transfer the drug to another container to maintain its quality.

Side effects

  • Hypotension
  • Neonatal Craniosynostosis
  • Anuria
  • Renal Failure
  • Oligohydramnios
  • Fetal Limb Hypoplasia
  • Craniofacial Malformation
  • Pulmonary Hypoplasia
  • Prematurity
  • Intrauterine Growth Restriction
Show 211 more
  • Patent Ductus Arteriosus
  • Dizziness
  • Headache
  • Drowsiness
  • Stroke
  • Weakness
  • Chest Discomfort
  • Chest Pain
  • Early Satiety
  • Peripheral Edema
  • Depressed Edema
  • Abdominal Discomfort
  • Indigestion
  • Nausea
  • Gastroesophageal Reflux Disease
  • Constipation
  • Itching
  • Urticaria
  • Palpitations
  • Flushing
  • Orthostatic Hypotension
  • Facial Flushing
  • Dyspnea
  • Cough
  • Dizziness (vertigo)
  • Eye Congestion
  • Frequent Urination
  • Fatigue
  • Edema
  • Lightheadedness
  • Abdominal Pain
  • Nausea
  • Weakness
  • Apathy
  • Pain
  • Weight Gain
  • Weight Loss
  • Hypotension
  • Vasculitis
  • Increased Tension
  • Sensory Decrease
  • Dysesthesia
  • Peripheral Neuropathy
  • Syncope
  • Ageusia
  • Tremor
  • Erectile Dysfunction
  • Gynecomastia
  • Change in Bowel Habits
  • Dry Mouth
  • Gastritis
  • Gingival Hyperplasia
  • Pancreatitis
  • Vomiting
  • Hyperglycemia
  • Arthralgia
  • Low Back Pain
  • Muscle Cramps
  • Myalgia
  • Leukopenia
  • Thrombocytopenia
  • Insomnia
  • Mood Changes
  • Cough
  • Rhinitis
  • Hair Loss
  • Increased Sweating
  • Purpura
  • Skin Discoloration
  • Toxic Epidermal Necrolysis
  • Tinnitus
  • Visual Disturbance
  • Increased Urination Frequency
  • Urination Disorder
  • Nocturia
  • Hepatitis
  • Jaundice
  • Elevated Liver Enzymes
  • Pruritus
  • Rash
  • Angioedema
  • Erythema Multiforme
  • Myocardial Infarction
  • Arrhythmia
  • Bradycardia
  • Ventricular Tachycardia
  • Atrial Fibrillation
  • Tachycardia
  • Ventricular Fibrillation
  • Blood Pressure Drop
  • Sinoatrial Block
  • Atrioventricular Block
  • Precordial Pain
  • Diarrhea
  • Loose Stools
  • Cutaneous Erythema
  • Papular Rash
  • Dizziness
  • Heat Sensation
  • Impaired Glucose Tolerance
  • Weakness
  • Muscle Cramps
  • Low Back Pain
  • Limb Pain
  • Congestion
  • Upper Respiratory Infection
  • Sinusitis
  • Diarrhea
  • Sinus Disorder
  • Pharyngitis
  • Myalgia
  • Insomnia
  • Swelling
  • Abdominal Pain
  • Angioedema
  • Palm Skin Shedding
  • Hemolysis
  • Facial Edema
  • Fever
  • Orthostatic Effects
  • Syncope
  • Angina Pectoris
  • Second-Degree Atrioventricular Block
  • Cerebrovascular Accident
  • Hypotension
  • Myocardial Infarction
  • Atrial Fibrillation
  • Loss of Appetite
  • Toothache
  • Flatulence
  • Gastritis
  • Anemia
  • Gout
  • Upper Limb Pain
  • Hip Joint Pain
  • Joint Swelling
  • Knee Pain
  • Musculoskeletal Pain
  • Shoulder Pain
  • Muscle Rigidity
  • Arthralgia
  • Arthritis
  • Fibromyalgia
  • Muscle Weakness
  • Anxiety
  • Anxiety Disorder
  • Ataxia
  • Confusion
  • Depression
  • Nightmares
  • Sensory Diminishment
  • Decreased Libido
  • Memory Impairment
  • Migraine
  • Neural Irritability
  • Panic Disorder
  • Sleep Disorder
  • Tremor
  • Bronchitis
  • Pharyngeal Discomfort
  • Nosebleed
  • Rhinitis
  • Respiratory Congestion
  • Hair Loss
  • Dermatitis
  • Dry Skin
  • Petechial Hemorrhage
  • Erythema
  • Photosensitivity
  • Itching
  • Rash
  • Sweating
  • Urticaria
  • Blurred Vision
  • Eye Burning
  • Joint Pain
  • Conjunctivitis
  • Dysgeusia
  • Tinnitus
  • Vision Impairment
  • Erectile Dysfunction
  • Nocturia
  • Urethral Infection
  • Dry Cough
  • Angioedema
  • Vasculitis
  • Anaphylactic Reaction
  • Liver Dysfunction
  • Intestinal Vascular Edema
  • Apathy
  • Thrombocytopenia
  • Rhabdomyolysis
  • Dysgeusia
  • Erythroderma
  • Hyperkalemia
  • Hyponatremia
  • Elevated ALT
  • Elevated Serum Creatinine
  • Elevated Liver Enzymes
  • Syncope
  • Loss of Consciousness
  • Acute Hepatitis
  • Fulminant Hepatitis
  • Anaphylaxis Syndrome
  • Excessive Peripheral Vasodilation
  • Reflex Tachycardia
  • Systemic Hypotension
  • Shock
  • Hypotension
  • Tachycardia
  • Bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is also important to keep it at room temperature between 1 and 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

For domestic use - 30 tablets/bottle, for export - 30 tablets/box [(10 tablets/PTPX3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.